Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sets New 52-Week High – Should You Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) shares reached a new 52-week high during mid-day trading on Friday . The company traded as high as $9.85 and last traded at $9.8340, with a volume of 3567 shares. The stock had previously closed at $9.53.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 3.8%

The company has a quick ratio of 5.74, a current ratio of 6.44 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $16.84 billion, a PE ratio of 15.46, a PEG ratio of 1.90 and a beta of 0.19. The stock’s fifty day simple moving average is $8.84 and its 200 day simple moving average is $8.65.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its quarterly earnings results on Monday, October 27th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.02. The business had revenue of $740.85 million for the quarter, compared to analysts’ expectations of $742.35 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. On average, sell-side analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.